(Q53607459)

16 May 2018

title

Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo-controlled study. (English)

1 reference

16 May 2018

1 reference

7

Zinsmeister AR

1 reference

16 May 2018

Park MI

1

1 reference

16 May 2018

Ferber I

2

1 reference

16 May 2018

Camilleri M

3

1 reference

16 May 2018

Allenby K

4

1 reference

16 May 2018

Trillo R

5

1 reference

16 May 2018

Burton D

6

1 reference

16 May 2018

publication date

1 January 2006

1 reference

16 May 2018

Neurogastroenterology and Motility

published in

1 reference

16 May 2018

volume

18

1 reference

16 May 2018

issue

1

1 reference

16 May 2018

page(s)

28-36

1 reference

16 May 2018

Motilin and clinical application

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Erythromycin enhances fasting and postprandial proximal gastric tone in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Perception of changes in wall tension of the proximal stomach in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one center's experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Erythromycin enhances oesophageal motility in patients with gastro-oesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Oral erythromycin and symptomatic relief of gastroparesis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Synthesis and in vitro evaluation of [Leu13]porcine motilin fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Pathophysiology and treatment of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Effects of erythromycin on gastrointestinal tract motility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Contractile effects and intracellular Ca2+ signalling induced by motilin and erythromycin in the circular smooth muscle of human colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Effect of oral erythromycin on colonic transit in patients with idiopathic constipation a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Octreotide enhances the accelerating effect of erythromycin on gastric emptying in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Erythromycin accelerates gastric emptying in a dose-response manner in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

Metoclopramide improves gastric motility in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00726.X

10.1111/J.1365-2982.2005.00726.X

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

release_cvleqrd57rfhvjidrjosk3sl3a

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cvleqrd57rfhvjidrjosk3sl3a

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16371080

1 reference

16 May 2018